CLA-2-29:OT:RR:NC:N2:238
Ms. Robyn Addabbo
InterChem Corporation
120 Route 17 North
PO Box 1579
Paramus, NJ 07652-1579
RE: The tariff classification of Zanamivir (CAS-139110-80-8) in bulk from India
Dear Ms. Addabbo:
In your letter dated October 7, 2009, you requested a tariff classification ruling.
The subject product, Zanamivir, is an antiviral drug and a neuraminidase inhibitor used for the treatment of uncomplicated acute illness due to influenza A and B virus.
The applicable subheading for the Zanamivir in bulk form will be 2932.99.9090, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with oxygen hetero-atom(s) only: Other: Other: Other: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free.
Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/.
This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov.
This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).
A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033.
Sincerely,
Robert B. Swierupski
Director
National Commodity Specialist Division